A rare case of hypocalcemia induced by nilotinib

A rare case of hypocalcemia induced by nilotinib

Chronic myelogenous leukemia (CML) is a myeloproliferative disorder characterized by increased proliferation of predominantly myeloid cells in the bone marrow and their accumulation in the peripheral blood. Nowadays, drugs known as tyrosine kinase inhibitors (TKIs) are the standard treatment for CML...

Full description

Bibliographic Details
Main Authors: Marija Petrić, Antonija Miljak, Tanja Miličević, Maja Radman
Format: Article
Language:English
Published: VBZ 2017-03-01
Series:Endocrine Oncology and Metabolism
Subjects:
Chronic myelogenous leukemia
tyrosine kinase inhibitors
nilotinib
side effects
hypocalcemia
QT interval
Online Access:http://eom.hdeo.eu/wp-content/uploads/2017/03/vol3-iss1-5Petric.pdf

Similar Items

Similar Items